https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Alterations to the Duodenal Microbiota are Linked to Gastric Emptying and Symptoms in Functional Dyspepsia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50452 Wed 26 Jul 2023 13:14:54 AEST ]]> Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42463 p < 0.002) and smallest with metronidazole (22.7%, p = 0.18). Overall, 8.9% (95% confidence interval: 3.9-13.9) of patients had AEs severe enough to discontinue antibiotic therapy. In PSC patients, antibiotic treatment results in a significant improvement in markers of cholestasis and MRS. Antibiotics, particularly vancomycin, may have a positive effect on PSC either via direct effects on the microbiome or via host-mediated mechanisms.]]> Wed 24 Aug 2022 11:23:40 AEST ]]> A role for primary care pharmacists in the management of inflammatory bowel disease? lessons from chronic disease: a systematic review https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38722 Wed 19 Jan 2022 09:36:08 AEDT ]]> Risk-based decision-making related to preprocedural coronavirus disease 2019 testing in the setting of GI endoscopy: management of risks, evidence, and behavioral health economics https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50857 Wed 07 Feb 2024 15:20:00 AEDT ]]> Link between celiac disease and inflammatory bowel disease https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42464 Tue 23 Aug 2022 13:35:17 AEST ]]> Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46015 0.5). Conclusions: In FD patients, the response to antimicrobial therapy with rifaximin is not influenced by concomitant IBS symptoms.]]> Tue 08 Nov 2022 18:38:07 AEDT ]]> Influence of cigarette smoking on the human duodenal mucosa-associated microbiota https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33993 Firmicutes, specifically Streptococcus and Veillonella spp. The relative abundance of the genus Rothia was also observed to be greater in current smokers; while in contrast, levels of Prevotella and Neisseria were lower. The MAM profiles and diversity of previous smokers were observed to be intermediate between current and never smokers. Smoking did not impact the total density of bacteria present on the mucosa. Conclusions: These data indicate the duodenal MAM of current smokers is characterised by reduced bacterial diversity, which is partially but not completely restored in previous smokers. While the precise mechanisms remain to be elucidated, these microbiota changes may in some part explain the adverse effects of smoking on mucosa-associated diseases of the GI tract. Smoking status requires consideration when interpreting MAM data.]]> Tue 03 Sep 2019 17:58:12 AEST ]]> The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celiac wheat sensitivity https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51213 Thu 24 Aug 2023 14:59:28 AEST ]]> Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41177 Thu 18 Apr 2024 12:11:34 AEST ]]> Inconsistent symptom clusters for functional gastrointestinal disorders in Asia: is Rome burning? https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36105 Thu 06 Feb 2020 13:29:07 AEDT ]]> Pathophysiology of irritable bowel syndrome https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:26024 Sat 24 Mar 2018 07:24:33 AEDT ]]> Development and Validation of a Patient-Reported Experience Measure for Gastrointestinal Endoscopy: The Comprehensive Endoscopy Satisfaction Tool (CEST) https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51261 Mon 28 Aug 2023 14:59:19 AEST ]]> Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43586 Mon 26 Sep 2022 12:31:48 AEST ]]> Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42367 Mon 22 Aug 2022 14:08:53 AEST ]]> Evaluation of a Multidisciplinary Integrated Treatment Approach Versus Standard Model of Care for Functional Gastrointestinal Disorders (FGIDS): A Matched Cohort Study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51423 Mon 04 Sep 2023 14:58:08 AEST ]]> Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49999 Fri 23 Jun 2023 11:40:47 AEST ]]> Induction of meal-related symptoms as a novel mechanism of action of the duodenal-Jejunal Bbpass sleeve https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40059 Fri 22 Jul 2022 10:05:54 AEST ]]>